GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Danapha Pharmaceutical JSC (HSTC:DAN) » Definitions » Accounts Payable

Danapha Pharmaceutical JSC (HSTC:DAN) Accounts Payable : ₫0.00 Mil (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Danapha Pharmaceutical JSC Accounts Payable?

Danapha Pharmaceutical JSC's Accounts Payable for the quarter that ended in . 20 was ₫0.00 Mil.


Danapha Pharmaceutical JSC Accounts Payable Historical Data

The historical data trend for Danapha Pharmaceutical JSC's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danapha Pharmaceutical JSC Accounts Payable Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Accounts Payable

Danapha Pharmaceutical JSC Semi-Annual Data
Accounts Payable

Danapha Pharmaceutical JSC Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Danapha Pharmaceutical JSC Accounts Payable Related Terms

Thank you for viewing the detailed overview of Danapha Pharmaceutical JSC's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Danapha Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.

Danapha Pharmaceutical JSC Headlines